Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fran Laurie

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group studyEdward C Halperin, Fran Laurie, T J Fitzgerald
International Journal of Radiation Oncology, Biology, Physics|May 21, 2013
Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature reviewAlysa Fairchild, William Straube, Fran Laurie, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Current calibration, treatment, and treatment planning techniques among institutions participating in the Children's Oncology GroupMarcia Urie, T J FitzGerald, David Followill, et al.
Hematology/Oncology Clinics of North America|November 1, 2019
Treatment Toxicity: RadiationThomas J FitzGerald, Maryann Bishop-Jodoin, Fran Laurie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Radiation field design in the ACOSOG Z0011 (Alliance) TrialReshma Jagsi, Manjeet Chadha, Janaki Moni, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology GroupLynn Million, James Anderson, John Breneman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IVJeff M Michalski, Jane Meza, John C Breneman, et al.
Pediatric Blood & Cancer|August 14, 2018
Feasibility and accuracy of UF/NCI phantoms and Monte Carlo retrospective dosimetry in children treated on National Wilms Tumor Study protocolsJohn A Kalapurakal, Mahesh Gopalakrishnan, Matthew Mille, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803Aaron C Spalding, Douglas S Hawkins, Sarah S Donaldson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 studyJohn Breneman, Jane Meza, Sarah S Donaldson, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group studyEdward C Halperin, Fran Laurie, T J Fitzgerald
International Journal of Radiation Oncology, Biology, Physics|May 21, 2013
Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature reviewAlysa Fairchild, William Straube, Fran Laurie, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Current calibration, treatment, and treatment planning techniques among institutions participating in the Children's Oncology GroupMarcia Urie, T J FitzGerald, David Followill, et al.
Hematology/Oncology Clinics of North America|November 1, 2019
Treatment Toxicity: RadiationThomas J FitzGerald, Maryann Bishop-Jodoin, Fran Laurie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Radiation field design in the ACOSOG Z0011 (Alliance) TrialReshma Jagsi, Manjeet Chadha, Janaki Moni, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology GroupLynn Million, James Anderson, John Breneman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IVJeff M Michalski, Jane Meza, John C Breneman, et al.
Pediatric Blood & Cancer|August 14, 2018
Feasibility and accuracy of UF/NCI phantoms and Monte Carlo retrospective dosimetry in children treated on National Wilms Tumor Study protocolsJohn A Kalapurakal, Mahesh Gopalakrishnan, Matthew Mille, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803Aaron C Spalding, Douglas S Hawkins, Sarah S Donaldson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 studyJohn Breneman, Jane Meza, Sarah S Donaldson, et al.
Pageof 4